CIK 0001921865 · <br>Emerging growth company
ASP Isotopes Inc.
Sign in to watch- Ticker
- ASPI
- Exchange
- Nasdaq
- Industry
- Miscellaneous Chemical Products
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 872618235
- Phone
- 202-756-2245
- Business address
- 2200 ROSS AVENUE, SUITE 4575E, DALLAS, TX, 75201
- 4 Open-market sale Chief Financial Officer sold 21,830 shares at $2.19 ($47,808)
- 4 Planned sale COO sold 22,500 shares at $2.11 ($47,565)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 15,000 shares at $2.68 ($40,200)
- 4 Open-market buy Director bought 8,000 shares at $2.70 ($21,600)
- 4 Planned sale COO sold 8,438 shares at $4.29 ($36,216)
- 4 Open-market sale EVP, Gen Counsel, Secretary sold 23,678 shares at $3.89 ($92,107)
- 4 Planned sale COO sold 25,000 shares at $3.91 ($97,625)
- 4 Planned sale Chairman and CEO sold 251,275 shares at an average $3.98 ($999,237)
- 4 Planned sale Chief Financial Officer sold 23,124 shares at $6.28 ($145,219)
- 4 Open-market sale EVP, Gen Counsel, Secretary sold 100,000 shares at $6.14 ($614,000)
- 4 Open-market sale Director sold 100,000 shares at an average $6.19 ($618,500)
- 4 Open-market sale Director sold 30,000 shares at $6.27 ($188,100)
- 4 Planned sale COO sold 8,438 shares at $7.00 ($59,058)
- 4 Planned sale Chairman and CEO sold 251,275 shares at an average $7.98 ($2,004,337)
- 4 Grant or award Chief Operating Officer acquired 800,000 shares (grant or award)
- 4 Grant or award EVP, Gen Counsel, Secretary acquired 400,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 840,000 shares (grant or award)
- 4 Planned sale COO sold 22,500 shares at $5.21 ($117,113)
- 4 Planned sale Chief Financial Officer sold 23,124 shares at $5.48 ($126,673)
Page 1 of 6 · 104 filings